Schulz-Knappe; Peter
Patent Applications and Registrations
Patent applications and USPTO patent grants for Schulz-Knappe; Peter.The latest application filed is for "melanoma checkpoint inhibitor detection and treatment".
- Schulz-Knappe; Peter - Hemmingen DE
- Schulz-Knappe; Peter - Frankfurt-am-Main DE
- Schulz-Knappe; Peter - Cobham GB
- SCHULZ-KNAPPE; Peter - Hannover DE
- Schulz-Knappe; Peter - Surrey GB
| Patent | Date |
|---|---|
| Isotopic methods for measurement of tryptophan and metabolites thereof Grant 11,320,438 - Koncarevic , et al. May 3, 2 | 2022-05-03 |
| Melanoma Checkpoint Inhibitor Detection And Treatment App 20210231663 - BUDDE; Petra ; et al. | 2021-07-29 |
| Mass spectrometric quantitation Grant 10,976,321 - Schulz-Knappe , et al. April 13, 2 | 2021-04-13 |
| Marker Sequences For Diagnosing And Stratifying Sle Patients App 20210055296 - LUKING; Angelika ; et al. | 2021-02-25 |
| Marker Sequences For Diagnosing And Stratifying Systemic Sclerosis Patients App 20210003590 - BUDDE; Petra ; et al. | 2021-01-07 |
| Marker sequences for diagnosing and stratifying SLE patients Grant 10,746,735 - Luking , et al. A | 2020-08-18 |
| Immuno-oncology For The Treatment Of Cancer App 20200150117 - ZUCHT; Hans-Dieter ; et al. | 2020-05-14 |
| Marker sequences for diagnosing and stratifying systemic sclerosis patients Grant 10,571,477 - Budde , et al. Feb | 2020-02-25 |
| Marker Sequences For Managing The Therapy Of Rheumatoid Arthritis Patients App 20190128884 - BUDDE; Petra ; et al. | 2019-05-02 |
| Marker Sequences For Rheumatoid Arthritis App 20190120834 - LUKING; Angelika ; et al. | 2019-04-25 |
| Isotopic Methods For Measurement Of Tryptophan And Metabolites Thereof App 20180246118 - Koncarevic; Sasa ; et al. | 2018-08-30 |
| Method for diagnosis of high-affinity binders and marker sequences Grant 10,060,911 - Mullner , et al. August 28, 2 | 2018-08-28 |
| Marker Sequences For Diagnosing And Stratifying Systemic Sclerosis Patients App 20170199202 - BUDDE; Petra ; et al. | 2017-07-13 |
| Mass Spectrometric Quantitation App 20170146544 - SCHULZ-KNAPPE; PETER ; et al. | 2017-05-25 |
| Marker Sequences For Diagnosing And Stratifying Sle Patients App 20170074875 - LUKING; Angelika ; et al. | 2017-03-16 |
| Mass spectrometric analysis Grant 9,470,692 - Baumann , et al. October 18, 2 | 2016-10-18 |
| Marker Sequences For Neuromyelitis Optica (nmo) And Use Thereof App 20150323529 - GOHLER; Heike ; et al. | 2015-11-12 |
| Marker Sequences For Rheumatoid Arthritis App 20150293120 - LUKING; Angelika ; et al. | 2015-10-15 |
| Method For Identifying Marker Sequences For Gynaecological Malignant Tumours App 20150177247 - LUKING; ANGELIKA ; et al. | 2015-06-25 |
| Novel Method For Identifying Specific Marker Sequences For Prostate Cancer App 20140371095 - Amersdorfer; Peter ; et al. | 2014-12-18 |
| Novel Method for Diagnosis of High-Affinity Binders and Marker Sequences App 20140309133 - Mullner; Stefan ; et al. | 2014-10-16 |
| Mass Spectrometric Analysis App 20110111513 - Baumann; Christian ; et al. | 2011-05-12 |
| Human circulating cytokine CC-1 App 20080234187 - Forssmann; Wolf-Georg ; et al. | 2008-09-25 |
| Human circulating cytokine CC-1 App 20050106678 - Forssmann, Wolf-Georg ; et al. | 2005-05-19 |
| Process for determining the status of an organism by peptide measurement Grant 6,875,616 - Forssmann , et al. April 5, 2 | 2005-04-05 |
| Human Circulating Cytokine Cc-1 App 20030105293 - FORSSMANN, WOLF-GEORG ; et al. | 2003-06-05 |
| Use of inhibitors of phosphodiesterase IV Grant 5,891,904 - Stief , et al. April 6, 1 | 1999-04-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 